Skip to content

Impedance Plethysmography Based Deep Vein Thrombosis Monitoring During Catheter-directed Thrombolysis

Impedance Plethysmography Based Deep Vein Thrombosis Monitoring During Catheter-directed Thrombolysis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07665320
Enrollment
40
Registered
2026-06-24
Start date
2025-07-17
Completion date
2027-12-01
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Vein Thrombosis (DVT)

Keywords

deep vein thrombosis, DVT

Brief summary

The purpose of this study is to collect data on blood circulation using a multi-frequency impedance plethysmography device developed in the ThrombUS+ project. Impedance plethysmography (IPG) is a non-invasive method that measures changes in blood volume using electrodes placed on the skin. The collected data will be used for device development, the improvement of diagnostic data analysis methods, and AI training. A total of 40 participants will be recruited for this study, with 20 healthy volunteers in Tampere University and 20 patients undergoing thrombolytic therapy for DVT at Tampere University Hospital.

Detailed description

This study aims to collect IPG data set from healthy volunteers and DVT patients using ThrombUS+ prototype device developed during the project and commercial IPG device as a reference. The data will be used to develop ThrombUS+ IPG device, its signal processing and analysis algorithms and to train ML models. Objectives of the study are to 1. Collect IPG data for developing signal processing, data analysis and ML algorithms for DVT detection and assessment. 2. Evaluate the performance of the developed methods to gold standard references including angiography, ultrasound imaging and venous occlusion plethysmography. 3. Investigate whether multi-frequency IPG measurement improves the performance of DVT detection compared to single frequency measurement and determine the optimal measurement frequency. 4. Investigate and compare different interventions to cause changes in venous blood volume for DVT detection, such as venous occlusion by thigh cuff, active respiration and muscle activation. Secondary objectives are 1\) To investigate methods for simulating DVT and to compare the performance of these methods for DVT simulation.

Interventions

DEVICEImpedance plethysmography IPG

IPG signal is measured with ThrombUS+ prototype device

DEVICEVenous Occlusion Plethysmography VOP

In VOP measurement, a temporal blood restriction is caused by an occlusive cuff blocking venous outflow but allowing arterial inflow. The cuff intervention causes a change in venous blood volume, and it can be measured by electrical impedance plethysmography (IPG).

OTHERBreathing and leg movement exercise

The first exercise is the Valsalva maneuver, where the subject first inhales and then pushes out the breath while the larynx is closed. In the second exercise, the subject inhales for approximately 10 seconds, holds the breath for approximately 5 seconds, and then breathes out. Finally, the subject moves the ankles to contract calf muscles, and further to cause changes in venous blood volume. The IPG signal is measured on both calves by ThrombUS+ prototype device during these exercises.

Sponsors

Tampere University
Lead SponsorOTHER
Tampere University Hospital
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for Patients group: * Age: 18 or older; * DVT detected on other lower limb; * Suitable for CDT treatment; * Ability to give informed consent; * Volunteering for the study.

Exclusion criteria

for Patients group: * Age under 18 years; * Inability to give informed consent; * Denial; * Too injured skin in the measurement area Inclusion Criteria for Healthy volunteers group: * Age: 18 or older; * Ability to give informed consent; * Volunteering for the study

Design outcomes

Primary

MeasureTime frame
Impedance plethysmography (IPG) data during CDT treatmentFrom enrollment to the end of the CDT treatment (up to 2 days)
Impedance plethysmography (IPG) data from healthy volunteersFrom enrollment to the end of measurements (up to 2 hours)

Countries

Finland

Contacts

CONTACTVehkaoja
antti.vehkaoja@tuni.fi+358407393181

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 30, 2026